|1.||Lurie, D M: 2 articles (09/2009 - 12/2008)|
|2.||Kent, M S: 2 articles (09/2009 - 12/2008)|
|3.||Théon, A P: 2 articles (09/2009 - 12/2008)|
|4.||Fossati-Bellani, F: 2 articles (06/2005 - 07/2001)|
|5.||Terenziani, M: 2 articles (06/2005 - 07/2001)|
|6.||Spreafico, F: 2 articles (06/2005 - 07/2001)|
|7.||Cefalo, G: 2 articles (06/2005 - 07/2001)|
|8.||Casanova, M: 2 articles (06/2005 - 07/2001)|
|9.||Ferrari, A: 2 articles (06/2005 - 07/2001)|
|10.||Massimino, M: 2 articles (06/2005 - 07/2001)|
|1.||Neoplasm Metastasis (Metastasis)
01/01/1992 - "A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases."
01/01/1992 - "Hemibody irradiation (HBI) in a single exposure is an effective and safe technique for palliation of symptoms due to widespread bony metastases (RTOG 78-10). "
01/01/2009 - "Half body irradiation of patients with multiple bone metastases: a phase II trial."
12/01/1999 - "There were encouraging results from the Radiation Therapy Oncology Group (RTOG) 82-06 study suggesting that half-body irradiation (HBI) should be used earlier in the disease course to prevent the development of metastases. "
08/01/1996 - "A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases--RTOG 88-22."
12/01/2010 - "Protection of bone marrow against radiotoxicity during radioimmunotherapy and in some cases external beam radiation therapy such as hemi-body irradiation would permit administration of significantly higher doses to tumors, resulting in increased efficacy and safety of treatment. "
08/01/1988 - "These pilot studies confirm the efficacy of sequential half body irradiations in systemic tumor therapy. "
02/01/2008 - "Biological estimation of dose in hemi-body irradiation of cancer patients by cytogenetic analysis."
10/01/2004 - "The tumor control effects by total-body irradiation (TBI) or half-body irradiation (HBI) on tumor-bearing mice and human cancer were investigated. "
10/01/2004 - "Radiobiological basis for cancer therapy by total or half-body irradiation."
12/01/1996 - "Radiation-induced emesis is a quite frequent event when total and half body irradiation or wide fields on the pelvis, abdomen and mediastinum are employed. "
11/15/1994 - "The degree of change following lower hemibody irradiation (15% incidence of emesis) in Group A was lower than upper/mid hemibody irradiation of the same group. "
11/15/1994 - "The incidence of emesis was significantly different (p < 0.001) between the patients of Group A and C who received upper/mid hemibody irradiation. "
11/15/1994 - "The incidence of radiation-induced emesis was 82% (14/17) following upper/mid hemibody irradiation and 15% (2/11) following lower hemibody irradiation in Group A; 50% (3/6) and 25% (1/4) following upper/mid and lower hemibody irradiation respectively, in Group B; and 0% (0/13) after upper/mid hemibody irradiation in Group C. "
12/01/1992 - "Radiation-induced emesis can occur (1) within 2 to 3 weeks in approximately 50% of patients after conventional fractionated radiotherapy (200 cGy/fraction) to the upper abdomen, (2) acutely in more than 90% of patients receiving fractionated total body irradiation (TBI) for bone marrow transplantation, and (3) within 30 to 60 minutes in more than 80% of patients following single high-dose (> 500 cGy)/large field hemibody irradiation (HBI). "
08/01/2009 - "Hemibody irradiation has been shown to relieve bony metastatic pain within 24-48 hours of treatment, whereas for local external beam radiation, onset of pain relief is 1-4 weeks after radiation. "
11/01/2008 - "The mean pain level decreased from 6.1 points (half-body irradiation) to 3.1 points 2 weeks later. "
10/01/2008 - "To determine whether patients receiving hemi-body irradiation required further treatment to painful bone sites out with the radiation field (skull or lower leg), whether patients required further treatment to areas within the treated radiation field for pain or new skeletal events, and whether the treatment outcome was successful in terms of pain control. "
05/01/1999 - "Better results in terms of pain relief (80% complete responses) and duration of palliation come from fractionated half-body irradiation (up to 17.5 Gy in 7 fractions), which however has a more delayed response (1-2 weeks) and higher toxicity. "
05/01/1999 - "Half-body irradiation can achieve complete pain relief in over 20% of patients and decrease pain markedly in the remaining cases with only a single-dose fraction (6-10 Gy), within 48 hours of irradiation and with little side-effects. "
09/01/1990 - "Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study."
11/01/1996 - "We report the results of treatment of 9 patients with advanced multiple myeloma (MM) using half-body irradiation. "
11/01/1996 - "Half-body irradiation in the treatment of multiple myeloma: a report of nine cases."
12/01/1995 - "Half-body irradiation in multiple myeloma."
01/01/1995 - "Double hemibody irradiation (DHBI) is an alternative treatment of stage III multiple myeloma (MM) in patients aged over 55 years. "
|5.||Teniposide (VM 26)
|6.||Serotonin (5 Hydroxytryptamine)
|7.||Morphine (MS Contin)
|1.||Drug Therapy (Chemotherapy)
|4.||Combination Drug Therapy (Combination Chemotherapy)